Nebulized Budesonide for Children with Mild-to-Moderate Croup

Authors:
  • MFMark E. Feldman
    Mark E. Feldman
  • LWLise K. Watters
    Lise K. Watters
  • TSTeresa Sutcliffe
    Teresa Sutcliffe
  • PRPeter C. Rowe
    Peter C. Rowe

Abstract
Although recent evidence has strongly supported the use of glucocorticoid therapy in children hospitalized with croup, the benefit of this therapy in children with less severe croup has not been documented. This randomized, double-blind trial compared a nebulized glucocorticoid, budesonide, with placebo in outpatients with mild-to-moderate croup.

This publication has 23 references indexed in Scilit: